Inter-relationships of risk factors and pathways associated with all-cause mortality in patients with chronic schizophrenia

被引:0
|
作者
Yu, Teng-Hung [1 ,2 ]
Lee, Thung-Lip [1 ,3 ]
Hsuan, Chin-Feng [1 ,2 ,4 ]
Wu, Cheng-Ching [1 ,2 ,5 ]
Wang, Chao-Ping [1 ,3 ]
Lu, Yung-Chuan [3 ,6 ]
Wei, Ching-Ting [7 ,8 ]
Chung, Fu-Mei [1 ]
Lee, Yau-Jiunn [9 ]
Tsai, I-Ting [2 ,10 ]
Tang, Wei-Hua [11 ,12 ]
机构
[1] I Shou Univ, E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan
[2] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[3] I Shou Univ, Coll Med, Sch Med Int Students, Kaohsiung, Taiwan
[4] I Shou Univ, E Da Dachang Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan
[5] I Shou Univ, E Da Canc Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan
[6] I Shou Univ, E Da Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan
[7] I Shou Univ, E Da Hosp, Dept Surg, Div Gen Surg, Kaohsiung 82445, Taiwan
[8] I Shou Univ, Coll Med, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan
[9] Lees Endocrinol Clin, Pingtung, Taiwan
[10] I Shou Univ, E Da Hosp, Dept Emergency, Kaohsiung, Taiwan
[11] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Yuli Branch, Hualien, Taiwan
[12] Natl Yang Ming Chiao Tung Univ, Fac Med, Sch Med, Taipei, Taiwan
来源
FRONTIERS IN PSYCHIATRY | 2024年 / 14卷
关键词
chronic schizophrenia; all-cause mortality; clinical and biochemical factors; lifestyle; comorbid illnesses; causal pathways; inter-relationship; Structural Equation Modeling; ACUTE-PHASE PROTEINS; PHYSICAL-ACTIVITY; DIABETES-MELLITUS; RELATIVE RISK; SERUM-ALBUMIN; PREVALENCE; DISEASE; METAANALYSIS; DIETARY; PEOPLE;
D O I
10.3389/fpsyt.2023.1309822
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction Of all psychiatric disorders, schizophrenia is associated with the highest risk of all-cause mortality. This study aimed to investigate independent risk factors for all-cause mortality in patients with chronic schizophrenia. In addition, the possible causal inter-relationships among these independent risk factors and all-cause mortality were also explored.Methods We conducted an analysis of 1,126 patients with chronic schizophrenia from our psychiatric department from April 2003 to August 2022, and retrospectively reviewed their medical records. The study endpoint was all-cause mortality. Baseline clinical characteristics including sociodemographic data, biochemical data, lifestyle factors, comorbidities and antipsychotic treatment were examined with Cox proportional hazards analysis.Results The all-cause mortality rate was 3.9% (44 patients). Multivariate Cox regression analysis revealed that several factors were independently associated with all-cause mortality, including diabetes mellitus (DM), hypertension, heart failure, gastroesophageal reflux disease (GERD), peptic ulcer disease, ileus, underweight, fasting glucose, triglycerides, albumin, and hemoglobin. Structural equation modeling (SEM) analysis revealed that several factors had statistically significant direct effects on all-cause mortality. Heart failure, hypertension, underweight, age at onset, and ileus showed positive direct effects, while albumin and hemoglobin demonstrated negative direct effects. In addition, several factors had indirect effects on all-cause mortality. GERD indirectly affected all-cause mortality through ileus, and peptic ulcer disease had indirect effects through albumin and ileus. Ileus, underweight, DM, and hypertension also exhibited indirect effects through various pathways involving albumin, hemoglobin, and heart failure. Overall, the final model, which included these factors, explained 13% of the variability in all-cause mortality.Discussion These results collectively suggest that the presence of DM, hypertension, heart failure, GERD, peptic ulcer disease, ileus, and underweight, along with lower levels of albumin or hemoglobin, were independently associated with all-cause mortality. The SEM analysis further revealed potential causal pathways and inter-relationships among these risk factors contributing to all-cause mortality in patients with chronic schizophrenia.
引用
收藏
页数:12
相关论文
共 50 条
  • [22] Risk Factors Associated with All-Cause Death Among Dialysis Patients with Diabetes
    Grzywacz, Anna
    Lubas, Arkadiusz
    Smoszna, Jerzy
    Niemczyk, Stanislaw
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [24] AGE-SPECIFIC IMPACTS OF RISK FACTORS ON ALL-CAUSE MORTALITY IN DIALYSIS PATIENTS
    Moromizato, Takuhiro
    Sakaniwa, Ryoto
    Iseki, Kunitoshi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I651 - I653
  • [25] Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
    Ferguson, Gary T.
    Singh, Dave
    Rabe, Klaus F.
    Jenkins, Martin
    Patel, Mehul
    Dorinsky, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [26] Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial
    Singh, D.
    Ferguson, T. G.
    Rabe, F. K.
    Jenkins, M.
    Patel, M.
    Dorinsky, P.
    PNEUMOLOGIE, 2022, 76 : S6 - S7
  • [27] Abnormal Serum Potassium is Associated With Risk of Chronic Kidney Disease Progression and All-Cause Mortality in Patients With Chronic Kidney Disease
    O'Connell, Samantha
    Stefanescu, Andrei R.
    Cueto, Jenilee
    He, Hua
    Chen, Jing
    Grams, Morgan
    Anderson, Amanda H.
    He, Jiang
    Mills, Katherine T.
    CIRCULATION, 2023, 147
  • [28] DIGOXIN USE IS ASSOCIATED WITH A HIGHER RISK OF ALL-CAUSE MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION
    Shah, M.
    Tsadok, M. Avgil
    Essebag, V.
    Jackevicius, C. A.
    Eisenberg, M. J.
    Pilote, L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S105 - S105
  • [29] Headache at onset is associated with lower risk of all-cause mortality in patients with ischemic stroke
    Korompoki, E.
    Vassilopoulou, S.
    Tountopoulou, A.
    Vemmou, E.
    Nikolakopoulos, I.
    Vemmos, K.
    Mitsikostas, D. D.
    CEREBROVASCULAR DISEASES, 2018, 45 : 100 - 100
  • [30] Risk of All-Cause Mortality in Diabetic Patients Taking β-Blockers
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    Shapiro, Martin F.
    Sugiyama, Takehiro
    MAYO CLINIC PROCEEDINGS, 2018, 93 (04) : 409 - 418